Lemur tyrosine kinase-3 (LMTK3) in cancer and evolution

Justin Stebbing; Aleksandra Filipović; Georgios Giamas

doi:10.18632/oncotarget.291

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing OncoTarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Editorial:

Lemur tyrosine kinase-3 (LMTK3) in cancer and evolution

Justin Stebbing _, Aleksandra Filipović and Georgios Giamas

PDF | HTML | How to cite | Order a Reprint

Oncotarget. 2011; 2:428-429. https://doi.org/10.18632/oncotarget.291

Metrics: PDF 2553 views | HTML 2713 views | ?

Abstract

Justin Stebbing, Aleksandra Filipović and Georgios Giamas

¹Department of Oncology and Surgery, Imperial College, Hammersmith Campus, London

Received: June 8, 2011; Accepted: June 9, 2011; Published: June 16, 2011;

Correspondence:

Justin Stebbing, email:

Abstract

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 291

Subscribe to TOC Alerts

Editorial:

Lemur tyrosine kinase-3 (LMTK3) in cancer and evolution

Abstract